Resultados de la búsqueda 751-760 of 14522 for Benign+intracranial+hypertension

  1. Diagnósticos y tratamientos - Mayo Clinic

    What medicines are you taking? Do you have health issues such as high blood pressure, high cholesterol, diabetes or another condition that could affect your ...

  2. Ensayos clínicos - Neurología

    The system (RC+S & PAD) provides intracranial EEG (iEEG) sensing, electrical brain stimulation, and machine learning algorithms running on the RC+S and PAD ...

  3. Ensayos clínicos - Neurología

    Magnetic Resonance Elastography of Traumatic Brain Injury. Rochester, Minn. This purpose of this pilot study is to determine if there are changes in mild TBI ...

  4. Neurología - Ensayos clínicos

    This randomized phase III trial compares memantine hydrochloride and whole-brain radiotherapy with or without hippocampal avoidance in reducing ...

  5. Ensayos clínicos - Neurología

    Cerebrospinal Fluid Biomarkers For Brain Tumors. Rochester, Minn. The purpose of this study is to help generate a repository of Cerebrospinal Fluid (CSF) ...

  6. Cirugía de aneurisma - Mayo Clinic

    Se rompió su aneurisma cerebral y tenía un 40 por ciento de posibilidades de sobrevivir. Los médicos de Mayo Clinic realizaron un procedimiento que le salvó ...

  7. Nefrología e hipertensión - Ensayos clínicos

    The purpose of this study is to use urinary exosomes to non-invasively identify (protein biomarkers) various conditions affecting the renal transplant.

  8. Ensayos clínicos - Neurología

    Cerebrospinal Fluid Biomarkers For Brain Tumors. Rochester, Minn. The purpose of this study is to help generate a repository of Cerebrospinal Fluid (CSF) ...

  9. Tumor benigno de los nervios periféricos - Médicos y departamentos - Mayo Clinic

    radiooncólogo. Phoenix, AZ. Áreas de desarrollo: Irradiación de todo el cuerpo, Radiocirugía estereotáctica cerebral, Braquiterapia , Radiocirugía ...

  10. Hematología - Ensayos clínicos - Mayo Clinic

    The purpose of this study is to compare the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden.